Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Diaceutics ( (GB:DXRX) ) is now available.
Diaceutics PLC announced it will release its audited final results for the year ending December 31, 2024, on May 13, 2025. The company will hold webinars for analysts and investors on the same day, providing insights into its financial performance and strategic direction, which could impact its market positioning and stakeholder interests.
More about Diaceutics
Diaceutics PLC is a leading technology and solutions provider in the pharma and biotech industry, offering end-to-end commercialization solutions for precision medicines. Their services include data analytics, scientific, and advisory services, facilitated by their platform DXRX – The Diagnostics Network ®.
YTD Price Performance: -0.22%
Technical Sentiment Signal: Sell
Current Market Cap: $133M
For detailed information about DXRX stock, go to TipRanks’ Stock Analysis page.